Introduction
Five trials in five locations in the United States involving 512 steers were conducted to evaluate the effect of monensin [ t o 0 mgld in .9 kg of supplement (~umensin@)] and estradiol-controlled release implants (cornpudose@) administered alone and in combination on average daily gain (ADG) in steers on pasture. The effect of energy supplementation on rate of gain was also evaluated in these same trials. Monensin, a fermentation product, and estrogenic anabolic implants are both considered growth promoters in pasture cattle. However, the modes of action of these two growth promoters are quite different. Monensin affects rumen fermentation t o favor increased propionate production (Perry et al., 1976; Richardson et al., 1976; Van Maanen et al., 1978) , which is more efficiently produced and utilized than acetate, while estrogenic anabolics are thought to increase rate of growth by increasing pituitary size (Struempler and Burroughs, 1959) and also secretion of growth hormone (Trenkle, 1970; Wagner et al., 1978) . Monensin has been used in combination with estrogens in both feedlot (Trenkle and Willham, 1977; Dinius et al., 1978) and pasture cattle (Utley et al., 1976; Corah, 1977) . When energy con'centration is not limiting (feedlot), the effect of monensin is primarily to improve feed conversion (Davis and Erhart, 1976; , however, in high roughage diets (pasture) monensin increases rate of gain (Oliver, 1975 ; Potter et al., 1976; Rouquette et al., 1980) . In one study the estrogen anabolic response was more than additive to ,that of monensin in pasture cattle (Utley et al., 1976) , whereas, in another case the combined treatments produced a growth response somewhat less than the sum of the two separate components (Corah, 1977 lease implant alone and in combination on rate of gain in pasture cattle.
Materials and Methods
A series of five trials were conducted over a wide range of geographical areas in the United States. Steers were used in all five locations and were predominantly of British breeding with an average starting weight for each trial ranging from 236 to 265 kg. Steers received no anabolic~ before initiation of the studies.
A split-plot design was used in these studies. The main plot treatments were: 1) supplement with monensin, 2) supplement and no monensin and 3) no supplement and no monensin. The split-plot treatments were with and without estradiol implants (table 1) .
Six pastures were used at each location for a total of 30 pastures. Steers at each location were ranked by weight, the heaviest one-half were assigned to a block of three pastures and the lightweight one-half to another block of three pastures. One-third of the cattle in each block were assigned t o each pasture of the three pastures in the block. The three main plot treatments were then assigned randomly to each of the three pastures of heavy cattle and each of the three pastures of lightweight cattle. The steers in each pasture were then paired by weight and an estradiol implant was assigned randomly to one steer in each pair. Pastures at each location were of uniform size and quality. Within each three-pasture block the steers were rotated among pastures every 2 wk. Water was available in eaEhpasture and supplements were fed in feed bunks located in the pastures. Weighing facilities were located within a short distance of all pastures.
The pastures were composed of grasses common to the particular location (table 2) . Supplement, with or without monensin, was fed it the rate of .45 kgahead-'.d-'
for the first 5 d of the trial and then .9 kg0head-led-' until the trial ended. The supplement in all five locations was composed of high energy ingredients locally available. Mineral supplement, either block or loose, was fed ad libitum in a mineral box in each pasture.
Monensin urnen ens in^)^ was administered in the supplement at a desired concentration of 220 mglkg. Samples were submitted for assay at the time of mixing. Assays averaged 92% of theoretical.
Estradiol implants (controlled release; Comp~d o s e @ )~ were cylindrical in shape (dimensions: 4.76 mm diameter, 3.0 cm in length) with the outer 500 pm containing estradiol-170 (E2$ crystals embedded in a silicone rubber matrix (20% E20, 80% silicone rubber). Each implant was placed subcutaneously in the posterior median surface of the ear using an implant needle with a bore diameter sufficient t o accommodate a 4.76-mm diameter implant. All implants were removed at termination of the trial with a tool designed to immobilize the implant in a groove that contains a surgical cutting edge. Ears were palpated every 28 d at time of weighing for the presence or absence of implants. Any missing implants were replaced. Implant loss during the trials ranged from 0 to 15% over the five locations. The average duration of all five trials was 124 d (range 112 to 140 d).
Steers were weighed twice at the initiation and termination of the trial and single interim weights were taken at approximate 28-d intervals.
Drug delivery was measured by implant weight loss at the end of the trial in all locations except one where individual implant identification was not recorded. Implant weight loss for each of the four trials is shown in table 3.
Data from the five trials were pooled and the variable, average daily gain (ADG), was analyzed using an analysis of variance. Main plot treatmen; means were compared using the Student-Newman- Keuls (Newman, 1939 ; Keuls, 1952 ) multiple comparison procedure, and variance homogeneity between trials was determined using Bartlett's (1937) test.
Routine animal health procedures employed at all trial locations included vaccination, anthelmintic treatment and external parasite treatment. A total of 10 steers were removed from the five trials for various reasons not related to the treatments.
Results and Discussion
The results from the analysis of variance (table 4) indicated a highly significant difference (P<.0003) in ADG among locations. The location by main plot treatment interaction was not significant (P<.09), indicating that the effects of the main plot treatments were the same for each location. Bartlett's (1937) test procedure was used to test for homogeneity of variance. The test was found to be nonsignificant (P>.20). The analysis also indicated that there was a significant difference (P<.0001) b~i v e implants not included in the average because a portion of the implant was missing. (1969) . Analyses were performed using statistical procedures given in SAS (1979).
b~e s t for location differences used pastures (locations) as the error term to compute F-ratio. Test for main plot treatments and location X main plot treatments used pasture X main plot treatments (locations) as the error term to compute F-ratios. The other terms given used the error term to compute the F-ratios.
he lack of significance for the term indicates that the split-plot treatments had the same effect independent of the main plot treatments.
among the main plot treatments, indicating that at least one pair of main plot treatment means was different. The analysis showed that: 1) there was a difference in ADG (P<.0001) among split-plot treatments (estradiol vs no estradiol) and 2) the split-plot and main plot neatments did not interact (P>.20), implying that the split-plot treatment effect was similar across main plot treatments.
These studies indicated that both monensin and estradiol increased ADG of steers on pasture as shown in the summary of estradiol and monensin main effects in b~a l u e s within parentheses are the percentage response above that of the negative controls (no monensin, no estradiol implants). a~e a n s are calculated by averaging those animals that did and did not receive estradiol implant for a given treatment. Thus, each mean consists of 2 0 observations that included two pastures for each main plot treatment in each of five trials (10) times the two split-plot treatments in each pasture.
b , c l d~e a n s with different superscripts are different from one another; b-d, c-d a t the .01 level and b-c at the .05 level, using Student-Newman-Keuls multiple comparison procedure. Supplementation (.9 kgld) increased ADG 12.4%.
The main effect of estradiol on ADG, along with the estradiol effect within each main plot treatment (control, supplement, monensin supplement), is given in table 7. Overall, estradiol increased ADG 15.6%. Within main plot treatments, increases in ADG of 14.1, 15.5 and 18.7%, respectively, were observed when animals receiving estradiol were compared with those not receiving estradiol. The estradiol responses were similar across the main plot treatments. However, the percentage response as well as absolute gain increases tended t o be greater as rate of gain was increased by supplement or monensin. This positive relationship between rate of gain and response t o estrogenic implants has been observed in other studies (Davis e t al., 1977) :
In summary, results of these five trials demonstrate that the effects of monensin and anabolic levels of estradiol on performance in beef cattle are additive. The gain response produced by monensin in pasture cattle is the result of more energy being available t o the animal through changes in ratios of volatile fatty acids, specifically, more propionic acid in relation t o acetic and butyric acids. The greater production of propionic acid results in more efficient conversion of feed energy t o energy that is usable by the animal. Anabolic levels of estradiol effect increased rates of gain, presumably by increasing secretion of growth hormone, which also affects efficiency and rate of growth. Because these t w o mechanisms affecting growth are different it would be expected that these t w o drugs would be additive relative t o their effect on rate of growth. a~h i r t y observations for overall mean (total number of split-plot pasture groups).
bSplit-plot treatments differ (P<.0001).
